Details for New Drug Application (NDA): 090600
✉ Email this page to a colleague
NDA 090600 describes GLYCOLAX, which is a drug marketed by Lannett Co Inc and is included in two NDAs. Additional details are available on the GLYCOLAX profile page.
The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and twenty-one drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and twenty-one drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
Summary for 090600
| Tradename: | GLYCOLAX |
| Applicant: | Lannett Co Inc |
| Ingredient: | polyethylene glycol 3350 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/PACKET | ||||
| Approval Date: | Oct 6, 2009 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/SCOOPFUL | ||||
| Approval Date: | Oct 6, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
